Cost-saving Purification Sterogene emphasizes high stability, NaOH cleanability, and long cycle life for chromatography resins, with Direct Capture technology that reduces filtration steps. This positions the company as a provider of cost-efficient purification solutions for biosimilar markets and manufacturers seeking lower production costs.

Biosimilar Targeting The focus on purity under biosimilar pricing pressures creates a compelling sales angle for customers needing reliable, scalable purification that lowers overall cost per dose while meeting regulatory quality standards.

Regulatory Alignment Sterogene highlights capability to meet FDA and EMA regulatory requirements, which can reassure potential customers navigating complex approvals and favor product adoption in both US and European markets.

Proof of Scale Resins validated for over 100 cycles and used in licensed pharmaceuticals demonstrate credibility in performance and durability, suggesting upsell opportunities to established biopharma manufacturers seeking dependable, reusable chromatography media.

Strategic Partnerships Recent collaboration with MiraCosta College and the Open Biopharma Research and Training Institute indicates a pathway for expanding visibility, potential co-development, and early adoption pilots with academic and training partners that can lead to early commercial engagements.